Adrestia Therapeutics

About:

Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells

Website: https://www.adrestia.com

Twitter/X: AdrestiaTherap

Top Investors: Ahren Innovation Capital, GlaxoSmithKline

Description:

Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.

Total Funding Amount:

172M GBP

Headquarters Location:

Babraham, Cambridgeshire, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)adrestia.com

Founders:

Gabriel Balmus, Rafael E. Carazo, Stephen Jackson, Yaron Galanty

Number of Employees:

11-50

Last Funding Date:

2020-12-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai